Skip to main content
  • Saved

made a Post

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial - PubMed

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33438437/

doi: 10.1161/CIRCULATIONAHA.120.049447. Online ahead of print. 1 Division of Cardiology, University of Colorado School of Medicine, Aurora, CO. 2 Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, INSERM U1148, Paris, France. 3 Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA.